H01.121

Clinical Causes: Autoimmune response where the body's immune system mistakenly attacks healthy skin tissue. Genetic predisposition that increases susceptibility to autoimmune diseases. Exposure to ultraviolet (UV) light which can trigger or worsen skin lesions. Environmental factors such as certain medications or stress affecting immune system functioning.

Key Symptoms: Red, scaly patches on the eyelid that may be raised or flat. Chronic skin inflammation that persists over time. Lesions with a well-defined border, often with a characteristic scaly or crusty surface. Potential skin atrophy leading to thinning or scarring of the affected area. In some cases, mild discomfort or sensitivity in the affected eyelid.

Diagnosis Path: Diagnosis typically involves a detailed clinical examination by a healthcare provider, who will assess the appearance and distribution of skin lesions. A skin biopsy may be performed to confirm the diagnosis and distinguish DLE from other skin conditions. Additionally, blood tests might be conducted to check for other signs of lupus or related autoimmune activity. It is important to evaluate for distant skin or systemic involvement and rule out other dermatological disorders.

Treatment Protocols: Topical corticosteroids to reduce inflammation and suppress immune response in the affected skin. Calcineurin inhibitors as an alternative to corticosteroids, particularly for sensitive areas like the eyelids. Photoprotection measures such as avoiding excessive UV exposure and using broad-spectrum sunscreens. Regular monitoring and follow-up with healthcare providers to assess treatment effectiveness and modify strategies if needed. In some cases, systemic medications like antimalarials may be prescribed if lesions are widespread or resistant to topical therapy. Skin care regimens that promote healing and prevent further irritation.